Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy

Medicine & Life Sciences

• Immunogenic Cell Death 100%
• Drug Delivery Systems 62%
• Pancreatic Neoplasms 59%
• Nanoparticles 46%
• Oxaliplatin 43%
• gemcitabine 17%
• Cell Death 16%
• Nanomedicine 13%
• Neoplasms 11%
• Therapeutics 10%
• Cytotoxic T-Lymphocytes 5%
• Fluorouracil 5%
• Doxorubicin 4%
• Dendritic Cells 4%
• Immunotherapy 4%
• Therapeutic Uses 4%
• T-Lymphocytes 3%

Engineering & Materials Science

• Cell death 93%
• Drug Delivery Systems 92%
• Nanoparticles 38%
• Tumors 24%
• Medical nanotechnology 13%
• T-cells 11%
• Cells 7%
• Dendritic Cells 6%
• Block copolymers 5%
• Encapsulation 4%

Chemistry

• Cell Death 67%
• Oxaliplatin 43%
• Drug 33%
• Inducer 29%
• Gemcitabine 18%
• Nanoparticle 6%
• 5-Fluorouracil 5%
• Apoptotic 4%
• Doxorubicin 4%
• Diblock Copolymer 4%
• Encapsulation 3%